Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of Bright Light Therapy in Patients Receiving First Line Immune Checkpoint Blockade

NCT07661966 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT07661966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07661966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of Bright Light Therapy in Patients Receiving First Line Immune Checkpoint Blockade
Lead sponsor
Weill Medical College of Cornell University
Phase
Not applicable
Overall status
Recruiting
Start date
October 3, 2026
Completion date
December 31, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin cancer), nsclc (non-small cell lung cancer)